Cargando…
CLCF1 Is a Novel Potential Immune-Related Target With Predictive Value for Prognosis and Immunotherapy Response in Glioma
BACKGROUND: Cardiotrophin-like cytokine factor 1 (CLCF1) has been described as an oncogene and a potential therapeutic target in a variety of cancers, but its role in glioma remains unknown. METHODS: Based on The Cancer Genome Atlas (TCGA), we conducted a bioinformatics analysis to investigate the c...
Autores principales: | Jiang, Yuan, Ji, Qiankun, Long, Xiaoyan, Wang, Peng, Tu, Zewei, Zhang, Xian, Zhu, Xingen, Huang, Kai, Li, Jingying |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8898905/ https://www.ncbi.nlm.nih.gov/pubmed/35265072 http://dx.doi.org/10.3389/fimmu.2022.810832 |
Ejemplares similares
-
Intrinsic immune evasion patterns predict temozolomide sensitivity and immunotherapy response in lower-grade gliomas
por: Tu, Zewei, et al.
Publicado: (2022) -
Sperm Autoantigenic Protein 17 Predicts the Prognosis and the Immunotherapy Response of Cancers: A Pan-Cancer Analysis
por: Tu, Zewei, et al.
Publicado: (2022) -
Protein Disulfide-Isomerase A3 Is a Robust Prognostic Biomarker for Cancers and Predicts the Immunotherapy Response Effectively
por: Tu, Zewei, et al.
Publicado: (2022) -
Transcriptional Patterns of Lower-Grade Glioma Patients with Distinct Ferroptosis Levels, Immunotherapy Response, and Temozolomide Sensitivity
por: Tu, Zewei, et al.
Publicado: (2022) -
Human Mitochondrial Ribosomal RNA Modification-Based Classification Contributes to Discriminate the Prognosis and Immunotherapy Response of Glioma Patients
por: Wang, Peng, et al.
Publicado: (2021)